Paoletti, Giovanni
 Distribuzione geografica
Continente #
NA - Nord America 1.979
AS - Asia 1.587
EU - Europa 706
SA - Sud America 452
AF - Africa 90
OC - Oceania 17
Continente sconosciuto - Info sul continente non disponibili 2
Totale 4.833
Nazione #
US - Stati Uniti d'America 1.940
SG - Singapore 927
BR - Brasile 387
CN - Cina 329
IT - Italia 216
VN - Vietnam 94
FI - Finlandia 93
IE - Irlanda 87
DE - Germania 55
NG - Nigeria 55
GB - Regno Unito 45
HK - Hong Kong 45
IN - India 45
FR - Francia 35
AR - Argentina 31
NL - Olanda 30
BD - Bangladesh 25
RU - Federazione Russa 22
SE - Svezia 19
ES - Italia 17
MX - Messico 17
CA - Canada 16
AU - Australia 15
ID - Indonesia 15
CZ - Repubblica Ceca 14
JP - Giappone 13
TR - Turchia 13
ZA - Sudafrica 13
AT - Austria 12
IQ - Iraq 11
PK - Pakistan 11
UA - Ucraina 11
BE - Belgio 10
EC - Ecuador 9
CL - Cile 8
EG - Egitto 8
PL - Polonia 8
IL - Israele 7
CO - Colombia 6
LT - Lituania 6
SA - Arabia Saudita 6
PH - Filippine 5
TW - Taiwan 5
LV - Lettonia 4
MA - Marocco 4
PT - Portogallo 4
UZ - Uzbekistan 4
VE - Venezuela 4
AE - Emirati Arabi Uniti 3
AL - Albania 3
BG - Bulgaria 3
IR - Iran 3
KE - Kenya 3
KG - Kirghizistan 3
KR - Corea 3
LB - Libano 3
PY - Paraguay 3
SN - Senegal 3
TH - Thailandia 3
AZ - Azerbaigian 2
DZ - Algeria 2
HU - Ungheria 2
KZ - Kazakistan 2
NP - Nepal 2
NZ - Nuova Zelanda 2
PE - Perù 2
TN - Tunisia 2
TT - Trinidad e Tobago 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BO - Bolivia 1
BY - Bielorussia 1
CH - Svizzera 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
GD - Grenada 1
GE - Georgia 1
GR - Grecia 1
HR - Croazia 1
IM - Isola di Man 1
MY - Malesia 1
NO - Norvegia 1
PA - Panama 1
PS - Palestinian Territory 1
RO - Romania 1
SI - Slovenia 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TJ - Tagikistan 1
TL - Timor Orientale 1
TM - Turkmenistan 1
UY - Uruguay 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 4.833
Città #
Singapore 285
The Dalles 236
Chandler 218
Shanghai 184
Wilmington 139
Dallas 128
Ashburn 124
Boardman 92
Helsinki 92
New York 90
Dublin 87
Beijing 65
San Mateo 63
Benin City 54
Los Angeles 43
Hong Kong 42
Ho Chi Minh City 38
Milan 34
Lawrence 33
Princeton 33
Santa Clara 30
Ann Arbor 29
Paris 27
São Paulo 26
Leawood 24
Hanoi 20
Naples 20
Seattle 20
London 19
Phoenix 16
Amsterdam 14
Council Bluffs 14
Fairfield 14
Curitiba 12
Rome 12
Belo Horizonte 11
Boston 10
Brasília 10
Pune 10
Brno 9
Munich 9
Tokyo 9
Woodbridge 9
Brooklyn 8
Corigliano Calabro 8
Mumbai 8
Rio de Janeiro 8
San Francisco 8
Warsaw 8
Atlanta 7
Genoa 7
Guarulhos 7
Hyderabad 7
Newark 7
Porto Alegre 7
Ambivere 6
Johannesburg 6
Jumet 6
Mexico City 6
Montreal 6
Nuremberg 6
Secaucus 6
Stockholm 6
Buffalo 5
Cairo 5
Campinas 5
Denver 5
Guayaquil 5
Philadelphia 5
Rochester 5
Assago 4
Brussels 4
Buenos Aires 4
Campo Grande 4
Florence 4
Harbin 4
Houston 4
Hải Dương 4
Itu 4
Joinville 4
Lutz 4
Moscow 4
Parma 4
Riga 4
Taiyuan 4
Vienna 4
Ankara 3
Bangkok 3
Bishkek 3
Cagliari 3
Cape Town 3
Charlotte 3
Chicago 3
Coimbra 3
Dakar 3
Detroit 3
Haiphong 3
Juiz de Fora 3
Lahore 3
Manaus 3
Totale 2.733
Nome #
NAPPREB study protocol: A pivotal clinical trial to investigate clinical efficacy and potential response biomarkers to Benralizumab treatment in chronic rhinosinusitis with nasal polyps 142
Very rapid improvement of extended nitric oxide parameters, associated with clinical and functional betterment, in patients with chronic rhinosinusitis with nasal polyps (CRSwNP) treated with Dupilumab 118
An academic allergy unit during COVID-19 pandemic in Italy. 102
Allergy clinics in times of the SARS-CoV-2 pandemic: an integrated model 99
Clinical presentation at the onset of COVID-19 and allergic rhinoconjunctivitis 81
Allergen immunotherapy for respiratory allergy: Quality appraisal of observational comparative effectiveness studies using the REal Life Evidence AssessmeNt Tool. An EAACI methodology committee analysis 78
Asthma from immune pathogenesis to precision medicine 75
Interleukin-5 in the Pathophysiology of Severe Asthma 73
Treatable traits in chronic rhinosinusitis with nasal polyps 73
Effect of an educational intervention delivered by pharmacists on adherence to treatment, disease control and lung function in patients with asthma 73
Alpha1-antitrypsin deficiency and asthma 73
Allergen immunotherapy and biologics in respiratory allergy: friends or foes? 73
Extended nitric oxide analysis in patients with chronic rhinosinusitis with nasal polyps, with or without associated asthma 70
Allergen immunotherapy: The growing role of observational and randomized trial "Real-World Evidence" 69
New therapeutic approaches with biological drugs for eosinophilic granulomatosis with polyangiitis 68
One year of mepolizumab. Efficacy and safety in real-life in Italy 68
Real-life studies of biologics used in asthma patients: key differences and similarities to trials 67
Validation of the Italian version of the Test of Adherence to Inhalers (TAI) 65
Clinical features associated with a doctor-diagnosis of bronchiectasis in the Severe Asthma Network in Italy (SANI) registry 64
Do the current guidelines for asthma pharmacotherapy encourage over-treatment? 61
The importance of being not significant: blood eosinophils and clinical responses do not correlate in severe asthma patients treated with Mepolizumab in real life. 61
New drugs in early-stage clinical trials for allergic rhinitis 60
Validation and Qualification of Biomarkers and Their Translation Into Pathway-Specific Diagnostic Tests 60
COVID-19 in Severe Asthma Network in Italy (SANI) patients: Clinical features, impact of comorbidities and treatments 60
Immunostimulants in respiratory diseases: Focus on Pidotimod 59
Community pharmacist's professional adaptation amid Covid-19 emergency: a national survey on Italian pharmacists 59
Type 2 Inflammation in Eosinophilic Esophagitis: From Pathophysiology to Therapeutic Targets 56
Fractional Exhaled Nitric Oxide (FENO) in the management of asthma: a position paper of the Italian Respiratory Society (SIP/IRS) and Italian Society of Allergy, Asthma and Clinical Immunology (SIAAIC) 54
Impact of asthma on bronchiectasis severity and risk of exacerbations 54
Inappropriate prescription of benzodiazepines in acutely hospitalized older patients 53
Nasal Polyposis Quality of Life (NPQ): Development and Validation of the First Specific Quality of Life Questionnaire for Chronic Rhinosinusitis with Nasal Polyps 53
Advancing Precision Medicine in Asthma: Evolution of Treatment Outcomes 52
Sarilumab in patients admitted to hospital with severe or critical COVID-19: a randomised, double-blind, placebo-controlled, phase 3 trial 51
Successful SARS-CoV-2 vaccine allergy risk-management: The experience of a large Italian University Hospital 50
Antihypertensive treatment changes and related clinical outcomes in older hospitalized patients 48
Airways Type-2 Related Disorders: Multiorgan, Systemic or Syndemic Disease? 47
Small airway dysfunction and obesity in asthmatic patients: a dangerous liaison? 47
Gastroesophageal reflux and asthma: when, how, and why 46
Biologics and airway remodeling in severe asthma 45
Sex-Differences in the Pattern of Comorbidities, Functional Independence, and Mortality in Elderly Inpatients: Evidence from the RePoSI Register 44
Antibiotic use and associated factors in a large sample of hospitalised older people 43
Reply to: Kow CS et al. Are severe asthma patients at higher risk of developing severe outcomes from COVID-19? 43
Sex Differences in Severe Asthma: Results From Severe Asthma Network in Italy-SANI 42
COPD and biologic treatment: state of the art 42
Comorbid allergic rhinitis and asthma: important clinical considerations 40
New Onset of Eosinophilic Granulomatosis with Polyangiitis Following mRNA-Based COVID-19 Vaccine 38
Biologics in severe asthma: the role of real-world evidence from registries 38
Artificial intelligence processing electronic health records to identify commonalities and comorbidities cluster at Immuno Center Humanitas 37
Care for Patients with Type-2 Chronic Rhinosinusitis 36
A 300 IR 5-grass pollen sublingual immunotherapy tablet-specific systematic review and meta-analysis confirms its clinical benefits for patients with allergic rhinoconjunctivitis with or without asthma 36
Local Allergic Rhinitis: Lights and Shadows of a Mysterious Entity 35
Sleep quality burden in chronic rhinosinusitis with nasal polyps and its modulation by Dupilumab 35
Radiological Versus Clinical 1-Year Outcomes of Dupilumab in Refractory CRSwNP: A Real-Life Study 35
Biologic drugs and allergen immunotherapy: potential allies 34
Clinical features and outcomes of elderly hospitalised patients with chronic obstructive pulmonary disease, heart failure or both 33
Real-world data: A relevant component in the framework of scientific evidence 33
Critical evaluation of asthma biomarkers in clinical practice 33
Prevalence of familial link in patients affected by chronic rhinosinusitis with nasal polyposis 32
The Prevalence of Immediate Hypersensitivity Reactions to the BNT162b2 mRNA Vaccine against SARS-CoV-2: Data from the Vaccination Campaign in a Large Academic Hospital 32
Mechanisms of Allergen Immunotherapy and Potential Biomarkers for Clinical Evaluation 31
Mortality rate and risk factors for gastrointestinal bleeding in elderly patients 31
Prevalence, characteristics and treatment of chronic pain in elderly patients hospitalized in internal medicine wards 31
SANI Clinical Remission definition: a useful tool in Severe Asthma management 30
ARIA–Italy managing allergic rhinitis and asthma in a changing world: The role of the Pharmacist 30
Editorial: pharmacotherapy and evidence-based medicine 30
Use, Abuse, and Misuse of Nasal Medications: Real-Life Survey on Community Pharmacist's Perceptions 29
Impulse oscillometry defined small airway dysfunction in asthmatic patients with normal spirometry: Prevalence, clinical associations, and impact on asthma control 29
Asthma management, focused on the use of oral corticosteroids: the opinions of Italian asthmatic patients 29
Comparison of evidence of treatment effects in randomized and nonrandomized studies on allergen immunotherapy 29
Allergen immunotherapy in Italy: How, when, and why—A real-world study conducted through a patient association 29
Questionnaire Validation: A User Guide for Allergy Research 29
Clinical remission in severe asthma: lights and shadows on an ambitious goal 29
Intranasal corticosteroid and antihistamine combinations in the treatment of allergic rhinitis: the role of the novel formulation olopatadine/mometasone furoate 28
Vaping effects on asthma: results from a web survey and clinical investigation 28
Comparability of Asthma Control Test (ACT) scores between self and physician administered test 28
Drug–drug interactions involving CYP3A4 and p-glycoprotein in hospitalized elderly patients 28
The Present and Future of Allergen Immunotherapy in Personalized Medicine 28
Hypersensitivity Reactions to Iodinated Contrast Media: A Narrative Review of Current Evidence and Clinical Challenges 28
Desensitization Protocols for Anti-SARS-CoV-2 Vaccines in Patients with High Risk of Allergic Reactions 28
Cross-Cultural Validation of the Short Version of the Questionnaire of Olfactory Disorders-Negative Statements into Italian: Towards Personalized Patient Care 28
Real-world effectiveness of mepolizumab in asthma: a systematic review and meta-analysis 27
Polyethylene Glycol and Polysorbate 80 Skin Tests in the Context of an Allergic Risk Assessment for Hypersensitivity Reactions to Anti-SARS-CoV-2 mRNA Vaccines 27
Asthma severity: the patient’s point of view 27
Outcomes of Non‐Mucosa Sparing Endoscopic Sinus Surgery (Partial Reboot) in Refractory Chronic Rhinosinusitis with Nasal Polyposis: An Academic Hospital Experience 27
Vocal biomarkers correlate with FEV1 variations during methacholine challenge 27
Editorial: pharmacotherapy and evidence-based medicine section 27
Patterns of infections in older patients acutely admitted to medical wards: data from the REPOSI register 27
Pattern of comorbidities and 1-year mortality in elderly patients with COPD hospitalized in internal medicine wards: data from the RePoSI Registry 27
Prevalence of use and appropriateness of antidepressants prescription in acutely hospitalized elderly patients 27
Oral Corticosteroid Abuse and Self-Prescription in Italy: A Perspective from Community Pharmacists and Sales Reports before and during the COVID-19 Era 26
Oral Immunotherapy with Standardized Peanut Extract: A Game-Changer for Peanut Allergy 26
Exhaled nitric oxide in asthma: from diagnosis to management 25
Editorial comment on “Environmental influences on childhood asthma: Climate change” 25
Hospital Care of Older Patients With COPD: Adherence to International Guidelines for Use of Inhaled Bronchodilators and Corticosteroids 25
Severe asthma and personalized approach in the choice of biologic 25
The Use of Molecular Allergy Diagnosis in Anaphylaxis: a Literature Review 25
Personalizing the approach to asthma treatment 25
New evidence in food allergies treatment 25
Prognostic relevance of glomerular filtration rate estimation obtained through different equations in hospitalized elderly patients 23
Statistical advice provided by ChatGPT regarding an accepted article in Allergy 23
Totale 4.474
Categoria #
all - tutte 36.742
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 36.742


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021246 0 0 0 0 0 84 31 23 46 27 3 32
2021/2022191 4 1 11 41 0 0 4 29 8 22 59 12
2022/2023618 80 48 50 75 65 40 0 41 112 46 43 18
2023/2024868 76 68 164 37 34 85 72 44 21 36 72 159
2024/20251.434 69 25 28 30 38 137 77 108 254 302 161 205
2025/20261.595 484 231 229 398 209 44 0 0 0 0 0 0
Totale 4.975